Table 2. Tumor and treatment characteristics of primary and secondary hepatic metastases treated with IRE (N=77).
Variable (N=77) | N (%) | |
---|---|---|
Tumor Size (cm) | Median (range) | 1.3 (0.5-6) |
Lesion Pathology | ||
Colorectal | 57 (74) | |
Hepatocellular | 7 (9) | |
Leiomyosarcoma | 5 (6) | |
Neuroendocrine | 4 (5) | |
Ampullary | 3 (4) | |
Cholangiocarcinoma | 1 (1) | |
Distance to Major Vasculature | ||
< 3mm | 55 (71.4) | |
3-5mm | 14 (18.2) | |
5-10mm | 2 (2.6) | |
>10mm | 6 (7.8) | |
Close to 1st degree bile duct | No | 53 (68.8) |
Yes | 24 (31.2) | |
IRE treatments per Lesion | Median (range) | 2 (1-7) |
Ablation Zone Size (cm) | Median (range) | 3 (1.5-8) |
IRE Combined with Other Procedures | 63 (82) | |
Non-anatomic hepatectomy | 50 (64) | |
Left lateral segmentectomy | 10 (13) | |
Caudate lobectomy | 5 (6) | |
Right lobectomy | 2 (3) | |
Segmentectomy | 13 (17) | |
Cholecystectomy | 8 (10) | |
Microwave ablation | 32 (41) | |
Radiofrequency ablation | 2 (3) | |
Distal pancreatectomy | 3 (4) | |
Partial gastrectomy | 1 (1) | |
Placement of hepatic arterial infusion pump | 15 (19) |